MustGrow Biologics Corp.
MGRO.V · TSXV
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CA$0 | CA$5 | CA$0 | CA$0 |
| % Growth | -91.6% | 72,630.4% | -49.7% | – |
| Cost of Goods Sold | CA$0 | CA$0 | CA$0 | CA$0 |
| Gross Profit | CA$0 | CA$4 | CA$0 | CA$0 |
| % Margin | 75.6% | 91.8% | 100% | 100% |
| R&D Expenses | CA$1 | CA$1 | CA$0 | CA$0 |
| G&A Expenses | CA$3 | CA$3 | CA$5 | CA$2 |
| SG&A Expenses | CA$4 | CA$4 | CA$5 | CA$3 |
| Sales & Mktg Exp. | CA$0 | CA$1 | CA$1 | CA$1 |
| Other Operating Expenses | CA$1 | CA$0 | CA$0 | CA$0 |
| Operating Expenses | CA$5 | CA$6 | CA$6 | CA$3 |
| Operating Income | -CA$5 | -CA$1 | -CA$6 | -CA$3 |
| % Margin | -1,284.9% | -17.1% | -85,750.5% | -23,398.2% |
| Other Income/Exp. Net | CA$0 | CA$0 | -CA$0 | -CA$0 |
| Pre-Tax Income | -CA$5 | -CA$1 | -CA$6 | -CA$3 |
| Tax Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Net Income | -CA$5 | -CA$1 | -CA$6 | -CA$3 |
| % Margin | -1,228.3% | -14.4% | -85,905.9% | -23,808.2% |
| EPS | -0.095 | -0.014 | -0.11 | -0.07 |
| % Growth | -596.3% | 87.6% | -57.1% | – |
| EPS Diluted | -0.095 | -0.014 | -0.11 | -0.07 |
| Weighted Avg Shares Out | 52 | 50 | 49 | 44 |
| Weighted Avg Shares Out Dil | 52 | 50 | 49 | 44 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Interest Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Depreciation & Amortization | -CA$0 | CA$0 | CA$0 | CA$0 |
| EBITDA | -CA$5 | -CA$1 | -CA$6 | -CA$3 |
| % Margin | -1,284.9% | -14.4% | -85,750.5% | -23,398.2% |